Staphylococcus epidermidis Sepsis in the Intensive Care Nursery: A Characterization of Risk Associations in Infants <1,000 g

Neonatology

Volumn 69, Issue 4, 1996, Pages 249-256

  Johnson Robbins, Lauren A ^a   El Mohandes, Ayman E ^a   Simmens, Samuel J ^c   Keiser, John F ^b  

^a Newborn Service   (United States)

^b Department of Pathology ^*  (United States)

^c GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

S. epidermidis; Sepsis; Staphylococcus epidermidist colonization; Steroids

Indexed keywords

STEROID;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FECES CULTURE; FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; HYPERALIMENTATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SKIN CULTURE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STEROID THERAPY;

BACTEREMIA; BIRTH WEIGHT; FECES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PARENTERAL NUTRITION, TOTAL; RISK FACTORS; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STEROIDS;

EID: 0029867511     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244318     Document Type: Article

References (34)

1. Fleer A, Senders RC, Visser MR, Bijlmer RP, Gerards LJ, Kraaijc-veld CA, Vcrhoef J: Septicemia due to coagulasc-ncgativc staphyloccoci in a neonatal intensive care unit: Clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis, Pediatr Infect Dis 1983:2:461-463.
2. Hall RT, Hall SL, Barnes WG, Izucgbu J, Rogolksy M, Zorbas I: Characteristics of coagulase-nega-tive staphylococci from infants with bacteremia, Pediatr Infect Dis J 1987;6:377-383.
3. Hall RT, Hall SL, Barnes WG, Riddell S: Colonization with slime-posi-tivc coagulasc-ncgativc staphylococci as a risk factor for invasive coagu-lasc-ncgative staphylococcal infections in neonates, J Pcrinatol 1988: 8:215-221.
4. Sidebottom DG, Freeman J, Platt R, Epstein MF, Goldman DA: Fifteen-year experience with bloodstream isolates of coagulase-nega-tive staphylococci in neonatal intensive care, J Clin Microbiol 1988:4: 713-718.
5. Freeman J, Goldman DA, Smith NE, Sidebottom DG, Epstein MF, Platt R: Association of intravenous lipid emulsion and coagulase-nega-tive staphylococcal bacteremia in neonatal intensive care units, N Engl J Med 1990:323:301-308.
6. Battisti O, Mitchison R, Davies PA: Changing blood culture isolates in a referral neonatal intensive care unit, Arch Dis Child 1981:56:775-778.
7. Munson DP, Thompson TR, Johnson DE, Rhame FS, VanDrunen N, Fcrrieri P: Coagulase-negative staphylococcal septicemia: Experience in a newborn intensive care unit, J Pediatr 1982:101:602-605.
8. Schmidt BK, Kirpalani HM, Corey M, Low DE, Phillip AGS, Ford-Jones EL: Coagulase-negative staphylococci as true pathogens in newborn infants: A cohort study, Pediatr Infect Dis J 1987:6:1026-1031.
9. Baumgart S, Hall SE, Campos JM, Polin RA: Sepsis with coagulase-negative staphylococci in critically ill newborns, J Dis Child 1983:137: 461-463.
10. Freeman J, Epstein MF, Smith NE, Platt R, Sidebottom DG, Goldman DA: Extra hospital stay and antibiotic usage with nosocomial coagu-lase-negativc staphylococcal bacteremia in two neonatal intensive care unit populations, Am J Dis Child 1990:144:324-329.
11. Goldman DA: Coagulase-negative staphylococci: Interplay of epidemiology and bench research, Am J Infect Control 1990:18:211-221.
12. Donowitz LG, Haley CE, Gregory WW, Wenzel RP: Neonatal intensive care unit bacteremia: Emergence of gram-positive bacteria as major pathogens, Am J Infect Control 1987:15:141-147.
13. Patrick CC, Kaplan SL, Baker CJ, Parisi JT, Mason EO: Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates, Pediatrics 1989: 84:977-985.
14. Baron EJ, Peterson LR, Fincgold SM: Diagnostic Microbiology, St, Louis, Mosby, 1994, p 92.
15. Anday EK, Talbot GH: Coagulase-negative staphylococcus bacteremia: A rising threat in the newborn infant, Ann Clin Lab Sci 1985:15: 246-251.
16. Valvano MA, Hartslcin AI, Morth-land VH, Dragoon ME, Potter SA, Reynolds JW, Crosa JH: Plasmid DNA analysis of Staphylococcus epi-dcrniidis isolated from blood and colonization cultures in very' low birth weight neonates, Pediatr Infect DisJ 1987;7:116-120.
17. Leyden J J: Bacteriology of newborn skin; in Maiback H, Boisils EK (eds): Neonatal Skin: Structure and Function, New York, Dekker, 1982.
18. D'Angio CT, McGowan KL, Baum-gart S, St Gerne J, Harris MC: Surface colonization with coagulase-ncgative staphylococci in premature neonates, J Pediatr 1989:114:1028-1034.
19. Scheille DW, Bjornson GL: Delta toxin activity in coagulase-negative staphylococci from the bowels of neonates, J Clin Microbiol 1988:26: 279-282.
20. Hall SL, Riddell SW, Barnes WG, Meng L, Hall RT: Evaluation of coagulase-negative staphylococcal isolates from serial nasopharyngeal cultures of premature infants, Diagn Microbiol Infect Dis 1990:13:17-23.
21. Goldman DA, Lcclair J, Macone A: Bacterial colonization of neonates admitted to an intensive care environment, J Pediatr 1978:93:288-293.
22. Noel GJ, Edelson PJ: Staphylococcus epidermidis bacteremia in neonates: Further observations and the occurrence of focal infection, Pediatrics 1984:74:832-837.
23. Fischer GW, Hunter KW, Wilson SR, Mease AD: Diminished bacterial defenses with intralipid, Lancet 1982:2:819-820.
24. Collaborative Dexamethasone Trial Group: Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial, Pediatrics 1991:88:421-427.
25. Cummings JJ, D'Eugcnio DB, Gross SJ: A controlled trial of dexa-methasonc in preterm infants at high risk for bronchopulmonary dysplasia, N Engl J Med 1989:320: 1505-1510.
26. Haikavy KL, Scanlon JW, Chowdiy PK, Grylack LJ: Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trial, J Pediatr 1989:115:979-983.
27. Avery GB, Fletcher AB, Kaplan M, Brudno DS: Controlled trial ofdexa-mcthasonc in respirator-dependent infants with bronchopulmonary dysplasia, Pediatrics 1985:75:106-111.
28. Kazzi NJ, Brans YW, Poland RL: Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who arc dependent on artificial ventilation, Pediatrics 1990:86:722-727.
29. Mammel MC, Green TP, Johnson DE, Thompson TR: Controlled trial of dexamethsonc therapy in infants with bronchopulmonary dysplasia, Lancet 1983;i: 1356-1357.
30. Mukwaya G: Immunosuppressive clTccts and infections associated with corticosteroid therapy, Pediatr Infect Dis J 1988:7:499-504.
31. Ashkenazi S, Leibovici L, Samra Z, Konisbergcr H, Drucker M: Risk factors for mortality due to bacteremia and fungemia in childhood, Clin Infect Dis 1992:14:949-951.
32. Meulcman J, Katz P: The immunologic effects, kinetics, and use of glu-cocorticosteroids, Med Clin North Am 1985:69:805-816.
33. Fauci AS, Dale DC: The effect of hydrocortisone on the kinetics of normal human lymphocytes, Blood 1975:46:235-243.
34. Cates KL, Goetz C, Rosenberg N, Pantschenko A, Rowe JC, Ballow M: Longitudinal development of specific and functional antibody in very low birth weight premature infants, Pediatr Res 1988:23:14-22.